Alkem Laboratories receives land allotment for new manufacturing facility in Ujjain
Alkem Laboratories · Pharmaceuticals & Biotechnology
Key highlights
- Allotment letter dated 18th March 2026 received from DMIC Vikram Udyogpuri Limited
- Land admeasuring about 30 acres allotted in DMIC Vikram Udyogpuri Limited, Phase–2, Ujjain
- Board approved investment up to ₹533 crore for phased development of greenfield formulations facility
Why it's rated notable: amount is ₹500 crore or more
Original filing
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 As Amended
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Alkem Laboratories
- Acquisition / mergerNotableAlkem Laboratories completes acquisition of majority stake in Occlutech Holding AG
- Acquisition / mergerNotableAlkem Laboratories acquires 79,36,50,794 shares of Alkem Medtech via rights issue
- Acquisition / mergerNotableAlkem Laboratories updates acquisition agreement for Occlutech Holding AG
Other fundraise / allotment filings this fortnight
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
- Chaman Metallics Limited announces H1 FY27 financial results and proposed Rights Issue
- Harmony Capital Services receives BSE approval for preferential issue of shares
- Kuber Udyog: open offer corrigendum, allotments of shares and warrants at ₹23.10
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.